Hypertension influences the exponential progression of inflammation and oxidative stress in streptozotocin-induced diabetic kidney
- PMID: 28163536
- PMCID: PMC5242028
- DOI: 10.4103/0976-500X.195898
Hypertension influences the exponential progression of inflammation and oxidative stress in streptozotocin-induced diabetic kidney
Abstract
Objective: To investigate the association of hypertension coexisting with diabetes mellitus with oxidative stress and inflammation in the kidneys of streptozotocin (STZ)-induced diabetic rats.
Materials and methods: Male Wistar rats were used for the experiments. Blood glucose (BG), urea, blood pressure (BP), and heart rate (HR) were analyzed before and 48 h after STZ injection. Further, these parameters were monitored up to 3 months of diabetes induction. Subsequently, the inflammatory markers (C-reactive protein, tumor necrosis factor-alpha, and nitrate) and oxidative stress markers were estimated after 3 months of diabetes induction in the kidney homogenate. Histological analysis of renal tissue was also carried out.
Results: Linear elevation of BG, urea, mean arterial pressure (MAP), and HR was observed up to 3 months of diabetes induction. In the same manner, inflammatory and oxidative stress markers were also found to be significantly increased. Notably, the histological analysis revealed the signs of nephropathy such as increased mesangial cell number, thickness of basement membrane, and renal artery. Inflammatory and oxidative stress markers positively correlated with elevated BP and BG, but the correlation was better with BP rather than BG.
Conclusion: Hypertension has a strong implication in the increased oxidative stress and inflammation of diabetic kidney at the very early stage of diabetes mellitus.
Keywords: Diabetes mellitus; diabetic nephropathy; hypertension; streptozotocin and oxidative stress.
Conflict of interest statement
There are no conflicts of interest.
Figures




Similar articles
-
Danshen injection ameliorates STZ-induced diabetic nephropathy in association with suppression of oxidative stress, pro-inflammatory factors and fibrosis.Int Immunopharmacol. 2016 Sep;38:385-94. doi: 10.1016/j.intimp.2016.06.024. Epub 2016 Jun 26. Int Immunopharmacol. 2016. PMID: 27355131
-
Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.Naunyn Schmiedebergs Arch Pharmacol. 2016 Dec;389(12):1315-1324. doi: 10.1007/s00210-016-1299-2. Epub 2016 Sep 9. Naunyn Schmiedebergs Arch Pharmacol. 2016. PMID: 27612855
-
Diltiazem attenuates oxidative stress in diabetic rats.Ren Fail. 2005;27(3):335-44. Ren Fail. 2005. PMID: 15957552
-
Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.Mol Cell Endocrinol. 2016 Dec 5;437:268-279. doi: 10.1016/j.mce.2016.06.029. Epub 2016 Jul 1. Mol Cell Endocrinol. 2016. PMID: 27378149
-
Effects of garlic extract on TNF-α expression and oxidative stress status in the kidneys of rats with STZ + nicotinamide-induced diabetes.Pharm Biol. 2017 Dec;55(1):526-531. doi: 10.1080/13880209.2016.1255978. Pharm Biol. 2017. PMID: 27937047 Free PMC article.
Cited by
-
Antioxidative Capacity of Liver- and Adipose-Derived Mesenchymal Stem Cell-Conditioned Media and Their Applicability in Treatment of Type 2 Diabetic Rats.Oxid Med Cell Longev. 2021 Feb 2;2021:8833467. doi: 10.1155/2021/8833467. eCollection 2021. Oxid Med Cell Longev. 2021. Retraction in: Oxid Med Cell Longev. 2024 Jan 9;2024:9854014. doi: 10.1155/2024/9854014. PMID: 33623636 Free PMC article. Retracted.
-
Altered profile of mRNA expression in atrioventricular node of streptozotocin‑induced diabetic rats.Mol Med Rep. 2017 Oct;16(4):3720-3730. doi: 10.3892/mmr.2017.7038. Epub 2017 Jul 20. Mol Med Rep. 2017. PMID: 28731153 Free PMC article.
-
Cardio-protective effects of a dioxidovanadium(V) complex in male sprague-dawley rats with streptozotocin-induced diabetes.Biometals. 2021 Feb;34(1):161-173. doi: 10.1007/s10534-020-00270-0. Epub 2020 Nov 18. Biometals. 2021. PMID: 33206308
References
-
- Jensen T, Borch-Johnsen K, Deckert T. Changes in blood pressure and renal function in patients with type I (insulin-dependent) diabetes mellitus prior to clinical diabetic nephropathy. Diabetes Res. 1987;4:159–62. - PubMed
-
- Parving HH. Controlling hypertension in diabetes. Acta Diabetol. 2002;39(Suppl 2):S35–40. - PubMed
-
- Tarnow L, Rossing P, Gall MA, Nielsen FS, Parving HH. Prevalence of arterial hypertension in diabetic patients before and after the JNC-V. Diabetes Care. 1994;17:1247–51. - PubMed
-
- Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension. 1992;19:403–18. - PubMed
-
- Cruickshanks KJ, Orchard TJ, Becker DJ. The cardiovascular risk profile of adolescents with insulin-dependent diabetes mellitus. Diabetes Care. 1985;8:118–24. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials